DE69413039D1 - Prostaglandin rezeptor fp und kodierende dns - Google Patents

Prostaglandin rezeptor fp und kodierende dns

Info

Publication number
DE69413039D1
DE69413039D1 DE69413039T DE69413039T DE69413039D1 DE 69413039 D1 DE69413039 D1 DE 69413039D1 DE 69413039 T DE69413039 T DE 69413039T DE 69413039 T DE69413039 T DE 69413039T DE 69413039 D1 DE69413039 D1 DE 69413039D1
Authority
DE
Germany
Prior art keywords
prostaglandin receptor
receptor
encoding dna
host cells
dna encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69413039T
Other languages
English (en)
Other versions
DE69413039T2 (de
Inventor
Mark Abramovitz
Richard Grygorczyk
Kathleen Metters
Truyen Nguyen
Thomas Rushmore
Deborah Slipetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Canada Inc
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of DE69413039D1 publication Critical patent/DE69413039D1/de
Publication of DE69413039T2 publication Critical patent/DE69413039T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69413039T 1993-06-25 1994-06-09 Prostaglandin rezeptor fp und kodierende dns Expired - Lifetime DE69413039T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/083,741 US5869281A (en) 1993-06-25 1993-06-25 DNA encoding prostaglandin receptor FP
PCT/CA1994/000319 WO1995000551A1 (en) 1993-06-25 1994-06-09 Prostaglandin receptor fp and dna encoding it

Publications (2)

Publication Number Publication Date
DE69413039D1 true DE69413039D1 (de) 1998-10-08
DE69413039T2 DE69413039T2 (de) 1999-05-06

Family

ID=22180389

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413039T Expired - Lifetime DE69413039T2 (de) 1993-06-25 1994-06-09 Prostaglandin rezeptor fp und kodierende dns

Country Status (9)

Country Link
US (3) US5869281A (de)
EP (1) EP0705276B1 (de)
JP (1) JP3228751B2 (de)
AT (1) ATE170532T1 (de)
AU (1) AU6991894A (de)
CA (1) CA2165954C (de)
DE (1) DE69413039T2 (de)
ES (1) ES2120052T3 (de)
WO (1) WO1995000551A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202892D0 (sv) 1992-10-02 1992-10-02 Kabi Pharmacia Ab Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
US6057433A (en) * 1993-11-19 2000-05-02 Allergan Sales, Inc. Nucleic acid encoding human EP3 prostaglandin receptor
US6670134B1 (en) 1993-11-19 2003-12-30 Allergan, Inc. Human EP3 prostaglandin receptor
US7294331B2 (en) 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
WO1996023066A2 (en) 1995-01-26 1996-08-01 Merck Frosst Canada Inc. Prostaglandin receptor, dp
US5955575A (en) * 1997-12-22 1999-09-21 Hopital Sainte-Justine Antagonists of G-protein-coupled receptor
US6984719B1 (en) 1998-09-17 2006-01-10 Hospital Sainte-Justine Peptide antagonists of prostaglandin F2α receptor
AU5722499A (en) 1998-09-17 2000-04-10 Hopital Sainte-Justine G protein-coupled receptor agonists or antagonists
WO2000029614A1 (en) * 1998-11-12 2000-05-25 Gemini Genomics Ab. Human prostaglandin receptors and methods of use thereof
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
MXPA02005626A (es) 1999-12-06 2004-09-10 Pital Sainte Justine H Composiciones para el tratamiento de filtracion glomerular, conductos arteriosos y osteoporosis del paciente.
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
DE60236951D1 (de) * 2001-05-21 2010-08-19 Fujifilm Corp Vorrichtung zur Durchführung biochemischer Analysen und Verfahren zu ihrer Herstellung
US7521530B2 (en) 2002-06-11 2009-04-21 Universite De Montreal Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
WO2004073590A2 (en) * 2003-02-24 2004-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for deseases associated with g-protein coupled receptor prostaglandin f2-alpha (prostaglandin f2-alpha)
US7320871B2 (en) * 2003-07-14 2008-01-22 Allergan, Inc. Human prostaglandin FP receptor variants and methods of using same
US20050074847A1 (en) * 2003-10-07 2005-04-07 Yanbin Liang Human prostaglandin EP1 receptor variants and methods of using same
US20050084929A1 (en) * 2003-10-17 2005-04-21 Yanbin Liang Human prostaglandin EP4 receptor variants and methods of using same
US20050084931A1 (en) * 2003-10-20 2005-04-21 Yanbin Liang Human prostaglandin DP receptor variants and methods of using same
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202892D0 (sv) * 1992-10-02 1992-10-02 Kabi Pharmacia Ab Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof

Also Published As

Publication number Publication date
US6358694B1 (en) 2002-03-19
US5840847A (en) 1998-11-24
AU6991894A (en) 1995-01-17
CA2165954C (en) 2005-04-26
WO1995000551A1 (en) 1995-01-05
JP3228751B2 (ja) 2001-11-12
US5869281A (en) 1999-02-09
JPH11505701A (ja) 1999-05-25
ES2120052T3 (es) 1998-10-16
CA2165954A1 (en) 1995-01-05
ATE170532T1 (de) 1998-09-15
DE69413039T2 (de) 1999-05-06
EP0705276A1 (de) 1996-04-10
EP0705276B1 (de) 1998-09-02

Similar Documents

Publication Publication Date Title
DE69413039T2 (de) Prostaglandin rezeptor fp und kodierende dns
ATE236932T1 (de) Dna kodierend für prostaglandin rezeptor ip
CA2170509A1 (en) Dna encoding prostaglandin receptor ep2
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
WO1996023066A3 (en) Prostaglandin receptor, dp
DE69405230T2 (de) Prostaglandinrezeptor ep1 kodierende dna
ATE196651T1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
DE69414109T2 (de) Prostaglandin rezeptor ep3 und kodierende dns
FI971276A (fi) Lerk-6:ksi nimetty sytokiini

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MERCK FROSST CANADA & CO, KIRKLAND, QUEBEC, CA

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK FROSST CANADA LTD., KIRKLAND, QUEBEC, CA